Pexidartinib: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Pexidartinib. Educational only — not medical advice.

Labeled uses

TURALIO is indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery.

Source: FDA labeling via NIH DailyMed (set 7b0ec4bf…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.